Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials

Clinical trials have shown that AS03-adjuvanted H5N1 and A(H1N1)pdm09 vaccines are highly immunogenic, although with an increased reactogenicity profile relative to non-adjuvanted vaccines in terms of the incidence of common injection site and systemic adverse events (AEs). We evaluated pooled safet...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hum Vaccin Immunother
Главные авторы: Vaughn, David W, Seifert, Harry, Hepburn, Anne, Dewe, Walthere, Li, Ping, Drame, Mamadou, Cohet, Catherine, Innis, Bruce L, Fries, Louis F
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2014
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5443104/
https://ncbi.nlm.nih.gov/pubmed/25483467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.972149
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы